| Literature DB >> 23473921 |
Alex P Young1, Ryan B Gruber, Joe F Discala, Walter J May, Dylan McLaughlin, Lisa A Palmer, Stephen J Lewis.
Abstract
We determined whether pretreatment with (1) the μ-/δ-opioid receptor (μ-/δ-OR) antagonist, naloxone, (2) the δ1,2-OR antagonist, naltrindole, or (3) the peroxynitrite scavenger, d-penicillamine, affects the development of tolerance to the ventilatory depressant effects of morphine in rats. The injection of morphine in vehicle-pretreated rats decreased minute ventilation predominantly via decreases in tidal volume. Pretreatment with naloxone blunted the responses to morphine whereas pretreatment with naltrindole or d-penicillamine did not. A second injection of morphine, given one day later, elicited markedly smaller responses in vehicle rats whereas it elicited pronounced ventilatory depression in rats that were pretreated with naloxone, naltrindole or d-penicillamine (prior to morphine) the day before. Moreover, the ventilatory responses elicited by subsequent exposure to a hypoxic-hypercapnic challenge were markedly depressed in naloxone- or d-penicillamine-pretreated rats compared to vehicle-pretreated rats. These findings suggest that activation of μ- and δ-ORs causes tolerance to the ventilatory depressant effects of morphine at least partly via the generation of peroxynitrite.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23473921 PMCID: PMC4451624 DOI: 10.1016/j.resp.2013.02.028
Source DB: PubMed Journal: Respir Physiol Neurobiol ISSN: 1569-9048 Impact factor: 1.931